Literature DB >> 2785130

Neuronal pathways to the rat middle meningeal artery revealed by retrograde tracing and immunocytochemistry.

R Uddman1, H Hara, L Edvinsson.   

Abstract

The origin of nerve fibers to the middle meningeal artery of rat was studied by retrograde tracing in combination with immunocytochemistry. Application of the retrograde tracer, True blue (TB), to the middle meningeal artery labeled nerve cell bodies in the ipsilateral superior cervical ganglion, the otic ganglion, the sphenopalatine ganglion, the jugular-nodose ganglionic complex, the trigeminal ganglion and the cervical dorsal root ganglion at level C2. A few nerve cell bodies were labeled in the contralaterally placed ganglia. Judging from the number of labeled nerve cell bodies, the ipsilateral superior cervical ganglion, the otic ganglion, the sphenopalatine and the trigeminal ganglia contribute most to its innervation. A moderate supply of labeled nerve cell bodies was seen in the cervical dorsal root ganglion at level C2 whereas there were only few in the jugular-nodose ganglionic complex. The TB-labeled nerve cell bodies were further examined for the presence of neuropeptides. For that purpose antibodies against neuropeptide Y (NPY), vasoactive intestinal polypeptide (VIP), calcitonin gene-related peptide (CGRP) and substance P (SP) were used. Most of the TB-labeled nerve cell bodies in the superior cervical ganglion exhibited NPY-immunoreactivity. In the sphenopalatine and otic ganglia the majority of the TB-labelled neurons were VIP-immunoreactive whereas in the trigeminal and dorsal root ganglion at level C2 the majority of labeled nerve cell bodies displayed CGRP-immunofluorescence and a minority of the labeled nerve cell bodies were substance P-immunoreactive. Together the findings indicate that several ganglia project to the middle meningeal artery of the rat and that many neuropeptides are involved in vasomotor control and in mediation of afferent information.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2785130     DOI: 10.1016/0165-1838(89)90109-4

Source DB:  PubMed          Journal:  J Auton Nerv Syst        ISSN: 0165-1838


  23 in total

1.  Inhibition of stimulated meningeal blood flow by a calcitonin gene-related peptide binding mirror-image RNA oligonucleotide.

Authors:  Thomas Denekas; Markus Tröltzsch; Axel Vater; Sven Klussmann; Karl Messlinger
Journal:  Br J Pharmacol       Date:  2006-04-24       Impact factor: 8.739

Review 2.  Calcitonin gene-related peptide antagonists as treatments of migraine and other primary headaches.

Authors:  Peter J Goadsby
Journal:  Drugs       Date:  2005       Impact factor: 9.546

3.  Developmental changes of mast cell populations in the cerebral meninges of the rat.

Authors:  Helen Michaloudi; Christos Batzios; Maria Chiotelli; Georgios C Papadopoulos
Journal:  J Anat       Date:  2007-09-06       Impact factor: 2.610

4.  Topography of functional subpopulations of neurons in the superior cervical ganglion of the rat.

Authors:  D L Flett; C Bell
Journal:  J Anat       Date:  1991-08       Impact factor: 2.610

5.  Innervation of the dura mater encephali of cat and rat: ultrastructure and calcitonin gene-related peptide-like and substance P-like immunoreactivity.

Authors:  K Messlinger; U Hanesch; M Baumgärtel; B Trost; R F Schmidt
Journal:  Anat Embryol (Berl)       Date:  1993-09

6.  Topography and distribution of nerve fibers in the posterior longitudinal ligament of the rat: an immunocytochemical and electron-microscopical study.

Authors:  M von Düring; B Fricke; A Dahlmann
Journal:  Cell Tissue Res       Date:  1995-08       Impact factor: 5.249

7.  5-HT(1D) receptor immunoreactivity in the sphenopalatine ganglion: implications for the efficacy of triptans in the treatment of autonomic signs associated with cluster headache.

Authors:  Jason J Ivanusic; Matthew M K Kwok; Andrew H Ahn; Ernest A Jennings
Journal:  Headache       Date:  2011-03       Impact factor: 5.887

Review 8.  CGRP receptor antagonism and migraine.

Authors:  Lars Edvinsson; Tony W Ho
Journal:  Neurotherapeutics       Date:  2010-04       Impact factor: 7.620

Review 9.  Modelling headache and migraine and its pharmacological manipulation.

Authors:  S E Erdener; T Dalkara
Journal:  Br J Pharmacol       Date:  2014-07-01       Impact factor: 8.739

Review 10.  Recent Advances in Pharmacotherapy for Migraine Prevention: From Pathophysiology to New Drugs.

Authors:  Jonathan Jia Yuan Ong; Diana Yi-Ting Wei; Peter J Goadsby
Journal:  Drugs       Date:  2018-03       Impact factor: 9.546

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.